Related Experiment Videos
Diabetic glycemic control and retinal blood flow
J E Grunwald1, A J Brucker, S S Schwartz
1Department of Ophthalmology, Scheie Eye Institute, Philadelphia, PA 19104.
Diabetes
|May 1, 1990
Summary
Strict glycemic control significantly impacts retinal blood flow in diabetic patients. A rapid decrease in retinal volumetric blood flow (Q) at 5 days predicts no retinopathy progression, while a lack of decrease may indicate future progression.
Area of Science:
- Ophthalmology
- Diabetology
- Medical Physiology
Background:
- Diabetic retinopathy is a leading cause of vision loss.
- Strict glycemic control is crucial for managing diabetes.
- The immediate impact of glycemic control on retinal hemodynamics is not fully understood.
Purpose of the Study:
- To investigate the effect of strict glycemic control on retinal volumetric blood flow rate (Q).
- To determine if early changes in Q predict retinopathy progression.
- To assess the relationship between glycemic control and retinal blood flow over time.
Main Methods:
- Study included 13 insulin-dependent diabetic patients.
- Laser Doppler velocimetry and monochromatic fundus photography were used to measure Q.
- Retinal volumetric blood flow (Q) was measured at baseline, 5 days, 2 months, and 6 months.
- Retinopathy levels were assessed using stereocolor fundus photographs.
Main Results:
- A significant decrease in Q (1.4 ± 0.9 µL/min) was observed at 5 days in eyes with no retinopathy progression (NP).
- Eyes with retinopathy progression (P) showed a nonsignificant increase in Q (1.2 ± 1.7 µL/min) at 5 days.
- Changes in Q at 5 days strongly correlated with retinopathy progression at 6 months (r = 0.79, P < 0.005).
- No significant changes in Q were observed at 2 and 6 months.
Conclusions:
- A rapid decrease in retinal volumetric blood flow (Q) within 5 days of strict glycemic control is associated with no progression of diabetic retinopathy.
- A lack of Q decrease at 5 days may predict retinopathy progression.
- Early changes in retinal hemodynamics could serve as a predictor for diabetic retinopathy progression.